Publicaciones en colaboración con investigadores/as de Hospital Universitario de Donostia (20)

2022

  1. Large granular lymphocyte leukaemia study at the University Hospital of Donostia

    Journal of Clinical Pathology, Vol. 75, Núm. 4, pp. 226-233

2021

  1. Prediction of liver iron overload in the Basque country (Spain) in patients referred for hyperferritinemia

    Digestive and Liver Disease

2020

  1. Dysmetabolic iron overload syndrome and its relationship with HFE gene mutations and with liver steatosis

    Digestive and Liver Disease

  2. H63/H63D genotype and the H63D allele are associated in patients with hyperferritinemia to the development of metabolic syndrome

    European Journal of Internal Medicine

2017

  1. Liver Iron concentration in patients referred to a secondary hospital for hyperferritinemia: Analysis of the different groups according to HFE mutations and the transferrin saturation index

    Hepatitis Monthly, Vol. 17, Núm. 1, pp. 1-5

  2. Two new HLA class I alleles described in a Spanish individual, HLA-A*11:01:01:04 and HLA-B*35:330

    HLA

2016

  1. Analysis of HFE mutations and non-HFE gene mutations (TFR2 and SLC40A1) in patients with phenotypic hemochromatosis from the basque country

    International Journal of Laboratory Hematology

  2. Report From the First and Second Spanish Killer Immunoglobulin-Like Receptor Genotyping Workshops: External Quality Control for Natural Killer Alloreactive Donor Selection in Haploidentical Stem Cell Transplantation

    Transplantation Proceedings

2015

  1. Gender and plasma iron biomarkers, but not HFE gene mutations, increase the risk of colorectal cancer and polyps

    Tumor Biology, Vol. 36, Núm. 9, pp. 6959-6963

  2. Impact of H63D mutations, magnetic resonance and metabolic syndrome among outpatient referrals for elevated serum ferritin in the Basque Country

    Annals of Hepatology, Vol. 14, Núm. 3, pp. 333-339

2014

  1. Informe del Taller Ibérico de Histocompatibilidad 2013. Componente de análisis de situación de procedimiento de pruebas cruzadas en guardias de trasplante de órganos

    Inmunologia, Vol. 33, Núm. 1, pp. 27-33

2011

  1. Características clínicas y evolutivas de una familia con hemocromatosis hereditaria tipo 1

    Gaceta Medica de Bilbao, Vol. 108, Núm. 2, pp. 42-48

  2. Letter to the Editor: Regarding " Hemochromatosis Genotypes and Risk of Iron Overload-A Meta-Analysis"

    Annals of Epidemiology

2010

  1. Significance of H63D homozygosity in a Basque population with hemochromatosis

    Journal of Gastroenterology and Hepatology (Australia), Vol. 25, Núm. 7, pp. 1295-1298

2008

  1. Porfiria cutánea tarda: Asociación con mutaciones HFE, hepatitis virales, alcohol y otros factores de riesgo en Guipúzcoa, País Vasco

    Revista Espanola de Enfermedades Digestivas, Vol. 100, Núm. 12, pp. 774-778

  2. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis

    World Journal of Gastroenterology, Vol. 14, Núm. 10, pp. 1521-1527

2005

  1. HIV-infected progressors and long-term non-progressors differ in their capacity to respond to an A-class CpG oligodeoxynucleotide

    AIDS, Vol. 19, Núm. 16, pp. 1924-1925

2004

  1. HLA-A*2402 and a microsatellite (D6S248) are secondary independent susceptibility markers to ankylosing spondylitis in basque patients

    Human Immunology, Vol. 65, Núm. 2, pp. 175-180

  2. Quantitative assessment of PML-RARa and BCR-ABL by two real-time PCR instruments: Multiinstitutional laboratory trial

    Clinical Chemistry, Vol. 50, Núm. 6, pp. 1088-1092

2001

  1. HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls

    European Journal of Human Genetics, Vol. 9, Núm. 12, pp. 961-964